Dr. Michael Biney a medical practitioner with New Crystal Health Services has called for support from non-governmental organizations (NGOs) and funding agencies to support treatment of breast cancer treatment, to address its rising cost.
He emphasized the urgent need for a collaborative approach to ensure that patients have access to affordable care and necessary resources. Dr. Biney highlighted that the financial burden of breast cancer treatment can be overwhelming, with costs potentially reaching up to GH₵ 20,000 for patients. He proposed a solution where, with the help of NGOs and health funding agencies, these costs could be shared or even fully covered. “For instance, if a patient’s treatment costs GH₵ 20,000, NGOs and health ministries could subsidize 50% of the expenses, reducing the patient’s out-of-pocket cost to GH₵ 10,000. Alternatively, they could take full responsibility for the treatment costs, ensuring that patients do not have to bear any financial burden”.
Dr. Biney acknowledged support from NGOs but urged them to increase funding and educational initiatives aimed at raising awareness about breast cancer, encouraging women to participate in regular screenings and seek prompt medical attention. He also called on health ministries and regulatory bodies to implement policies that promote affordable treatment options for breast cancer patients.
By fostering partnerships among various stakeholders, Dr. Biney believes Ghana can enhance healthcare access and mitigate the adverse impact of breast cancer on individuals and families affected by the disease.
There are about 1.7 million new cases and 522 000 deaths from breast cancer each year. Breast cancer is the most common cancer in women worldwide, and is the most common cause of cancer among women in most countries. In low- and middle-income countries the incidence has been rising steadily due to increased life expectancy, changing reproductive patterns (such as later age at first childbirth and less breast-feeding), and the adoption of western lifestyles.
Early diagnosis remains the cornerstone of breast cancer control.
